Evaluation of PLG0206 in Prevention of Recurrent Infection in Patients Undergoing Debridement, Antibiotics, and Implant Retention (DAIR) for Treatment of a Periprosthetic Joint Infection (PJI) Following Knee Arthroplasty

PHASE2/PHASE3Not yet recruitingINTERVENTIONAL

Enrollment

240

Participants

Timeline

Start Date

December 31, 2025

Primary Completion Date

June 30, 2028

Study Completion Date

September 30, 2028

Conditions

Prosthetic-joint Infection

Interventions

DRUG

PLG0206

PLG0206 Solution

DRUG

Placebo